↓ Skip to main content

Nuclear Signaling Pathways and Targeting Transcription in Cancer

Overview of attention for book
Cover of 'Nuclear Signaling Pathways and Targeting Transcription in Cancer'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Steroid Receptor Coactivators (SRCs) as Integrators of Multiple Signaling Pathways in Cancer Progression
  3. Altmetric Badge
    Chapter 2 Role of Alteration/Deficiency in Activation (ADA) Complex in Cell Cycle, Genomic Instability and Cancer
  4. Altmetric Badge
    Chapter 3 RUNX2 Transcriptional Regulation in Development and Disease
  5. Altmetric Badge
    Chapter 4 Epigenetic Mechanisms of Cancer Metastasis
  6. Altmetric Badge
    Chapter 5 Regulatory Effects of Arsenic on Cellular Signaling Pathways: Biological Effects and Therapeutic Implications
  7. Altmetric Badge
    Chapter 6 Nuclear Factors Linking Cancer and Inflammation
  8. Altmetric Badge
    Chapter 7 Regulation of the Jak/STATs Pathways by Histone Deacetylases
  9. Altmetric Badge
    Chapter 8 Receptor Tyrosine Kinases in the Nucleus: Nuclear Functions and Therapeutic Implications in Cancers
  10. Altmetric Badge
    Chapter 9 Nucleolar Signaling Determines Cell Fate: The RP-Mdm2-p53 Axis Fine-Tunes Cellular Homeostasis
  11. Altmetric Badge
    Chapter 10 Transcriptional Regulation of Lipogenesis as a Therapeutic Target for Cancer Treatment
  12. Altmetric Badge
    Chapter 11 Selective Inhibition of Acetyl-Lysine Effector Domains of the Bromodomain Family in Oncology
  13. Altmetric Badge
    Chapter 12 Domain Specific Targeting of Cancer
  14. Altmetric Badge
    Chapter 13 The Potential of Targeting Splicing for Cancer Therapy
  15. Altmetric Badge
    Chapter 14 Exploiting Cell Cycle Pathways in Cancer Therapy: New (and Old) Targets and Potential Strategies
  16. Altmetric Badge
    Chapter 15 Histone Demethylases in Prostate Cancer
  17. Altmetric Badge
    Chapter 16 Therapeutic Significance of Chromatin Remodeling Complexes in Cancer
Attention for Chapter 13: The Potential of Targeting Splicing for Cancer Therapy
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
The Potential of Targeting Splicing for Cancer Therapy
Chapter number 13
Book title
Nuclear Signaling Pathways and Targeting Transcription in Cancer
Published in
Cancer Drug Discovery and Development, January 2016
DOI 10.1007/978-1-4614-8039-6_13
Book ISBNs
978-1-4614-8038-9, 978-1-4614-8039-6
Authors

Ana Rita Grosso Ph.D., Maria Carmo-Fonseca M.D., Ph.D., Ana Rita Grosso, Maria Carmo-Fonseca

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Professor 2 67%
Student > Bachelor 1 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 67%
Pharmacology, Toxicology and Pharmaceutical Science 1 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2014.
All research outputs
#17,732,227
of 25,992,468 outputs
Outputs from Cancer Drug Discovery and Development
#1
of 1 outputs
Outputs of similar age
#249,920
of 408,624 outputs
Outputs of similar age from Cancer Drug Discovery and Development
#1
of 1 outputs
Altmetric has tracked 25,992,468 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1 research outputs from this source. They receive a mean Attention Score of 1.0. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 408,624 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them